Citadel Advisors’s CytRx Corp CYTR Stock Holding History

Citadel Advisors’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,500	Closed	-$7K	–	8599
2017 Q1	$7K	Buy	+2,500	New	+$6.33K	﹤0.01%	7348
2016 Q3	–	Sell	-4,083	Closed	-$55K	–	8294
2016 Q2	$55K	Buy	+4,083	New	+$67.9K	﹤0.01%	6393
2015 Q3	–	Sell	-1,217	Closed	-$27K	–	9689
2015 Q2	$27K	Sell	1,217 -2,866	-70%	-$71.8K	﹤0.01%	8031
2015 Q1	$83K	Buy	4,083 +3,416	+512%	+$63.6K	﹤0.01%	7001
2014 Q4	$11K	Sell	667 -5,033	-88%	-$78.5K	﹤0.01%	8123
2014 Q3	$87K	Buy	5,700 +333	+6%	+$6.58K	﹤0.01%	6539
2014 Q2	$135K	Buy	+5,367	New	+$122K	﹤0.01%	5962
2014 Q1	–	Sell	-1,567	Closed	-$59K	–	8328
2013 Q4	$59K	Buy	+1,567	New	+$28.5K	﹤0.01%	5956

Other funds holding CYTR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

CTA

Colonial Trust Advisors Spartanburg, South Carolina $1.29B AUM 19.9% 1-Year Est. Return

Citadel Advisors's CYTR Position: Q1 2019 in Review

Citadel Advisors sold out of CytRx Corp (CYTR) in Q1 2019, closing a stake of 34,569 shares — an estimated $21.7K sold.

Citadel Advisors first reported a position in CYTR in Q2 2013 and held it in 13 quarters. The position peaked at $225K in Q4 2015. 35 funds tracked by Wall St. Rank hold CYTR as of Q1 2019.

Citadel Advisors reported no remaining CytRx Corp position as of Q1 2019 after selling out during the quarter.
Citadel Advisors sold 34,569 CytRx Corp shares in Q1 2019, an estimated $21.7K.
Citadel Advisors first reported a position in CytRx Corp in Q2 2013 and held it in 13 quarters.
Citadel Advisors's CytRx Corp position peaked at $225K in Q4 2015.
35 funds tracked by Wall St. Rank held CytRx Corp as of Q1 2019.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.